Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/31/2008CN101333251A Artificial zinc finger protein transcription factor capable of starting A20 gene expression and use
12/31/2008CN101333250A Plant stress related protein MASTER applications thereof for encoding gene
12/31/2008CN101333245A Method for separating human serum albumin
12/31/2008CN100447247C Recombinant infectious non-segmented negative strand RNA virus
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses
12/31/2008CN100447158C Neutralizable epitope of HGF and neutralizing antibody binding to the same
12/31/2008CN100447157C Androgen receptor compound relative protein
12/31/2008CN100447156C T2R taste receptors and genes encoding same
12/31/2008CN100447155C Recombinant human endothelial growth arrestin with activity of inhibiting endothelial cell growth
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447150C Isolation of lectins
12/31/2008CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes
12/31/2008CN100446810C Non-neurotoxic plasminogen activating factors for treating stroke
12/31/2008CA2692986A1 Compositions for anti-fibrinolytic treatment
12/31/2008CA2692171A1 Methods and uses thereof of prosaposin
12/31/2008CA2691849A1 Kallikrein 7 modulators
12/31/2008CA2691784A1 Composition and method for treatment of autoimmune disease
12/31/2008CA2691755A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
12/31/2008CA2691745A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
12/31/2008CA2690943A1 Conjugates containing hydrophilic spacer linkers
12/31/2008CA2690844A1 Fsh producing cell clone
12/31/2008CA2690802A1 Novel bacillus thuringiensis gene with lepidopteran activity
12/31/2008CA2690371A1 Peptide having hypotensive activity
12/31/2008CA2689569A1 Linear expression constructs for production of influenza virus particles
12/31/2008CA2688589A1 Intradermal hpv peptide vaccination
12/31/2008CA2687159A1 Peptides as antimicrobial agents towards campylobacter spp
12/31/2008CA2685533A1 Vaccine against clostridium perfringens
12/30/2008US7470838 Inbred corn line PH8JV
12/30/2008US7470837 Inbred corn line G1105
12/30/2008US7470836 Plants and seeds of hybrid corn variety CH645346
12/30/2008US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions
12/30/2008US7470779 Process for decreasing aggregate levels of pegylated protein
12/30/2008US7470777 Compositions and methods related to modified retroviral vectors for restricted, site specific integration
12/30/2008US7470776 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
12/30/2008US7470774 Anti-pro1477 antibodies
12/30/2008US7470771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/30/2008US7470770 Gene encoding malic enzyme and method for preparing succinic acid using the same
12/30/2008US7470769 Epidermal growth factor receptor antagonists and methods of use
12/30/2008US7470675 Methods for treating cancer using interferon-ω-expressing polynucleotides
12/30/2008US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents
12/30/2008US7470669 modulates an activity of the Lipolysis Stimulated Receptor, mechanisms of leptin elimination; for the treatment of obesity and obesity-related diseases and disorders; antilipemic agents
12/30/2008US7470667 Methods of treating cancer using a modified endostatin protein
12/30/2008US7470665 Antiproliferatory agents; antitumor agents; mixture of fibroblast growth factor and cytolysis agent
12/30/2008US7470663 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/30/2008US7470661 Delivery of superoxide dismutase to neuronal cells
12/30/2008US7470658 Methods for inhibiting tumor metastasis, and peptides useful therefor
12/30/2008US7470534 Mutated AQP, method for detecting cancer using the same, DNA chip having oligonucleotides of said mutated AQP sequence
12/30/2008US7470528 DNA encoding hydroxylase
12/30/2008US7470523 Recombinant protein production in a human cell
12/30/2008US7470522 Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2
12/30/2008US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer
12/30/2008US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease
12/30/2008US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2313380C Method for creating polynucleotide and polypeptide sequences
12/30/2008CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
12/30/2008CA2245545C Vaccines against varicella zoster virus gene 63 product
12/30/2008CA2197683C Method for preparing an influenza virus, antigens obtained and applications thereof
12/30/2008CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses
12/30/2008CA2117612C Periplasmic membrane-bound system for detecting protein-protein interactions
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/25/2008US20080319183 Branched Polymeric Sugars and Nucleotides Thereof
12/25/2008US20080319178 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319175 Transthyretin Stabilization
12/25/2008US20080319174 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319173 Blood group antigen fusion polypeptides and methods of use thereof
12/25/2008US20080319171 Continuous process for production of oil seed protein isolate
12/25/2008US20080319170 Methods and Uses of Antibodies in the Purification of Interferon
12/25/2008US20080319169 Biomimetic materials for protein storage and transport
12/25/2008US20080319168 Method for Coating Surfaces with Hydrophobins
12/25/2008US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
12/25/2008US20080319166 Treatment of implantable medical devices resistant to calcification
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
12/25/2008US20080319163 Method for Isolating and Purifying Immuno-Modulating Polypeptide from Cow Placenta
12/25/2008US20080318943 Compounds and Uses Thereof - 848
12/25/2008US20080318867 Virulent Phages to Control Listeria Monocytogenes in Foodstuffs and in Food Processing Plants
12/25/2008US20080318860 High Activity Growth Factor Mutants
12/25/2008US20080318859 Methods for Tissue Engineering
12/25/2008US20080318858 comprises a modified amino acid sequence comprising one or more amino acid substitutions to an amino acid sequence; substitutions are selected from the group consisting of H98Y, E102K, E108K, E120K; use as complement inhibitor
12/25/2008US20080318857 Compositions and Methods for the Intracellular Disruption of Vegf and Vegfr-2 By Intraceptors
12/25/2008US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient
12/25/2008US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin
12/25/2008US20080318852 Epitopes Related to Coeliac Disease
12/25/2008US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
12/25/2008US20080318850 Glycopegylated Factor Ix
12/25/2008US20080318845 Selective Vpac2 Receptor Peptide Agonists
12/25/2008US20080318841 Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug
12/25/2008US20080318840 Compositions of Alpha-Fetoprotein and Inducers of Apoptosis for the Treatment of Cancer
12/25/2008US20080318839 Ligand activated transcriptional regulator proteins
12/25/2008US20080318838 Peptides
12/25/2008US20080318835 Novel Integrin Ligand ITGL-TSP
12/25/2008US20080318790 Process for the Production of Fine Chemicals
12/25/2008US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity
12/25/2008US20080318337 Method for Determining a Tissue Degradation Process by Detection of Comp Neoepitopes
12/25/2008US20080318312 Pancreatic islet transcription factor and uses thereof
12/25/2008US20080318296 Mutant Glycoprotein Resistant to Modification with Asparagine-Linked Sugar Chain
12/25/2008US20080318281 Thermostabillization of Dna Polymerase by Protein Folding Pathway from a Hyperthermophile Archaeon, Pyrococcus Furiosus
12/25/2008US20080318277 Expression of human milk proteins in transgenic plants
12/25/2008US20080318275 Hepatitis C virus asialoglycoproteins